CN102114049A - Method for producing bee pollen tablets for treating premature ovarian failure of women - Google Patents
Method for producing bee pollen tablets for treating premature ovarian failure of women Download PDFInfo
- Publication number
- CN102114049A CN102114049A CN2010106074388A CN201010607438A CN102114049A CN 102114049 A CN102114049 A CN 102114049A CN 2010106074388 A CN2010106074388 A CN 2010106074388A CN 201010607438 A CN201010607438 A CN 201010607438A CN 102114049 A CN102114049 A CN 102114049A
- Authority
- CN
- China
- Prior art keywords
- bee pollen
- women
- water soluble
- water
- ovarian failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a method for producing bee pollen tablets for treating premature ovarian failure of women, relating to the technical field of production of tablet products. The method comprises the steps of: after pulverizing by air stream and wall-breaking treatment, immersing cleaned bee pollen in water with normal pressure and normal temperature; carrying out ultrasonication; centrifuging by a refrigerated centrifuger at a rotating speed of 8000-10000 revolutions; taking a supernate; separating a bee pollen water soluble substance with a molecular weight less than 4800D from the supernate at an ambient temperature of -5-5 DEG C; carrying out vacuum freeze drying on the bee pollen water soluble substance with a molecular weight less than 4800D to obtain lyophilized bee pollen with a water content less than 4%; and mixing the lyophilized bee pollen with water-soluble starch and preparing into tablets. The bee pollen tablets prepared by the method of the invention are used for treating premature ovarian failure of women by utilizing a bee pollen water soluble extract, and have the advantages of obvious effect, no side effect, low cost, simplicity, and practicability.
Description
Technical field
The present invention relates to product tablet production technology, particularly treat the tablet manufacturing method of women's premature ovarian failure.
Background technology
Tablet grows up on the pill basis, is created 19th-century forties, updates along with the development of compression machinery to 19 end of the centurys, and the application of tablet has obtained development rapidly.In recent ten years, tablet manufacturing technology and plant equipment aspect have bigger development, as boiling granulating, direct compression of full-powder, half film coating etc.The research of Chinese medicinal tablet and production start from the fifties in last century, and along with the comprehensive study of Chemistry for Chinese Traditional Medicine, pharmacology, preparation and aspect such as clinical, the kind of Chinese medicinal tablet, quantity constantly increase, and Technology is improved day by day, and the quality of tablet improves gradually.Chinese medicinal tablet on type except that general compressed tablet, coated tablet, also have microencapsule tablet, buccal tablet, external sheet and effervescent tablet etc.Find out a cover gradually at the tablet manufacturing process aspect and be applicable to the process conditions that Chinese medicinal tablet is produced, as preparation to fatty oil and volatile oil tablet, how to improve Chinese medicinal tablet hardness, improve disintegration, tablet coating etc. and accumulate experience gradually, quality is improved constantly.In addition, to the research of aspects such as the dissolution rate of Chinese medicinal tablet Chinese medicine and bioavailability, progressively carrying out.In a word, at present tablet become wide in variety, output is big, purposes is wide, use and store and transport conveniently, one of steady quality dosage form, tablet all accounts for more than 1/3 in the preparation that the pharmacopeia of China and other many countries is recorded, visible use wide.
The women that premature ovarian failure (POF) is meant normal development caused ovarian function failure with preceding because of certain reason at 40 years old.It shows as secondary amenorrhea, low estrogen and high promoting sexual gland hormone state, and custom is referred to as menopause early.The sickness rate of premature ovarian failure is about 1% one 3% before 40 years old, and the sickness rate in 30 years old is 0.1%.Research at present thinks that the number of primordial germ cell deposit is the key factor of decision female fertility phase length, and the formation of primordial germ cell is subjected to the control of a plurality of genes.Except that being subjected to congenital heredity factor regulation and control, keeping of mature women's ovarian function also is subjected to posteriori influence of various factors, and the true cause of its morbidity fully aware of not still up to now is so become the focus and the difficult point of domestic and international reproductive development circle to the research of this disease.
At present, premature ovarian failure still lacks ideal Therapeutic Method.To having fertility to require or preventing too early dotard, generally can take the method for Comprehensive Treatment to nurse one's health.Western medicine has certain effect, and mainly is complementing estrogen, but has bigger risk, need use progestogen under doctor's guidance simultaneously.When using estrogen and progestogen therapy according to the study, have certain effect, can improve symptom, but unsatisfactory to the recovery of ovarian function, mainly show discontinue medication after, symptom reappears, lutropin and follicule-stimulating hormone (FSH) raise once again, that is to say, Western medicine has only played the effect that takes stopgap measures, particularly, act on not ideal enough to the conceived women who requires is arranged.
Bee pollen is angiospermous pollen, and China utilizes and edible bee pollen country the earliest in the world.Whole nation bee pollen output is very abundant, and annual renewable product 3 kilotons because bee pollen is an insect pollination system, will be wasted if the resource of bee pollen can not in time be gathered and process.
The research of China's bee pollen at present is in the leading level in the world; external research also is in the primary research stages such as analysis of nutritional labeling; and a series of difficult problems such as China has solved well that bee pollen is fresh-keeping, breaking cellular wall and production; realized large-scale production; and improved alimentation rate behind the edible bee pollen greatly, for bee pollen industry leading position in the world provides powerful guarantee.However external bee pollen product is but more extensive on using than China, and Sweden is applied to beauty treatment with bee pollen food, and Japan is used as nutriment with bee pollen food, and France is with the function food of bee pollen as the growth encourage childhood development.By comparison, though the developmental research of China's bee pollen has been carried out the more than ten years, a large amount of bee pollen products has appearred, but the comprehensive processing and utilization level is also not high, the product category of existing bee pollen is single on the market, and quality is uneven, and the degree of intensive processing is not high yet, exported product is rare especially, and the resource of valuable bee pollen is not well utilized.
But because the easy moisture absorption moisture regain of the long-time storage of the lyophilized powder of the bee pollen water extract that tradition is collected, it is sticking to cause product to be stained with, and has both influenced product quality, makes the reduction of tiring of product activity, influences product again and takes, and greatly influences the product use.
Summary of the invention
The object of the invention be to invent a kind of be beneficial to long preservation, and can effectively keep the production method of its active bee pollen treatment women premature ovarian failure tablet.
The present invention includes following steps:
1) bee pollen with remove impurity is immersed in the normal pressure and temperature water after the comminution by gas stream broken wall treatment, with ultrasonic Treatment, through rotating speed is 8000～10000 refrigerated centrifuger centrifugal treating of changeing, get supernatant, again with supernatant under-5～5 ℃ ambient temperature, cross the following molecular sieve of 4800D, isolate the bee pollen hydrotrope of molecular weight less than 4800D;
2) with molecular weight less than the bee pollen hydrotrope of 4800D after lyophilisation, obtain water content and be lower than 4% Herba leucadis ciliatae lyophilized powder;
3) with described Herba leucadis ciliatae lyophilized powder and water soluble starch mixing film-making.
The present invention utilizes bee pollen water extract treatment women premature ovarian failure effect remarkable, and has no side effect, and expense is cheap, and is simple.Products characteristics after the present invention's processing is: packing dosage is accurate; Reservation function material activity; Medicine is difficult for oxidation deterioration; Easily absorb; Rehydration is good; Be fit to long-distance transport, long preservation and use.
In addition, the frequency of the classification motor of comminution by gas stream broken wall treatment is 55～60Hz in the step 1) of the present invention, and bleed pressure is 0.7～1.0MPa.
Ultrasonic treatment time described in the described step 1) is 10～20 minutes.
Described step 2) during lyophilisation, temperature of charge is-40 ℃～70 ℃ when sublimation drying and desorbing, and vacuum condition is 3～7Pa.
Mass ratio when lyophilized powder and water soluble starch mix in the described step 3) is 1 ︰ 0.1～10.
In described step 3), also can sneak into lecithin and microcrystalline Cellulose PH102 film-making; Mass ratio when described lyophilized powder, lecithin, water soluble starch and microcrystalline Cellulose PH102 mix is 1 ︰, 0.1～10 ︰, 0.1～10 ︰ 0.1～10.
The specific embodiment
One, the lyophilized powder of preparation treatment women premature ovarian failure bee pollen water extract:
1, go-on-go pollen: remove impurity in the bee pollen at normal temperatures.
2, breaking cellular wall: is 55～60Hz with the bee pollen of remove impurity in the frequency of classification motor, broken wall treatment under bleed pressure 0.7～1.0MPa.
3, soak supersound process: the bee pollen after the broken wall treatment is immersed in the normal pressure and temperature water, with ultrasonic Treatment 10～20 minutes.
4, remove impurity: it is centrifugal 8～12 minutes of 8000～10000 refrigerated centrifugers that change that the material after the supersound process is placed rotating speed, removes solid impurity, gets supernatant.
5, ultrafiltration: supernatant under-5～5 ℃ ambient temperature, is crossed the following molecular sieve of 4800D, isolate the hydrotrope of molecular weight, be the bee pollen hydrotrope that is used for the treatment of women's premature ovarian failure less than 4800D.
6, lyophilization: the bee pollen hydrotrope that will be used for the treatment of women's premature ovarian failure is-30 ℃～70 ℃ at temperature of charge, and vacuum condition is lyophilization 30～50 hours under the condition of 3～7Pa, obtains water content and is lower than 4% lyophilized powder.
Two, tabletting:
1, prescription A: the weight ratio with lyophilized powder, lecithin, water soluble starch and microcrystalline Cellulose PH102 is 1 ︰, 0.1～10 ︰, 0.1～10 ︰, 0.1～10 weighing respectively.
Prescription B: the weight ratio with lyophilized powder and water soluble starch is 1 ︰ 0.1～10.
2, production technology:
Mix: two kinds of prescriptions are put into respectively in the batch mixer, are built cover, open the batch mixer counter-rotating and stirred 10～20 minutes, just changeing again and stirring 5 minutes, behind the mix homogeneously, the material that mixes crossed 18 mesh sieves after, form two kinds of compounds, standby.
Tabletting: with two kinds of compounds difference tablettings.
Environmental condition is a relative humidity 45%～65% between the control tabletting, 18 ℃～26 ℃ of temperature, and it is 6～10kg/mm that tabletting hardness requires
2, sheet heavily is 0.6 gram.
Coating: syrup is with film coating pre-mix dose and 55%(percent by volume) ethanol continue to stir and became syrup in about 1 hour, cross 100 mesh sieves after, carry out coating.
Three, application and curative effect:
Certain woman, 40 years old, the premature ovarian failure symptom shows as estradiol and follicle stimulating hormone is unusual.
Take 2～4 in the bee pollen tablet made every day, after 30～60 days, taking a turn for the better appears in gonadal hormone and gonadotrophin secretion continuously, and recovers normal gradually.
Claims (7)
1. be used for the treatment of the production method of the bee pollen tablet of women's premature ovarian failure, it is characterized in that may further comprise the steps:
1) bee pollen with remove impurity is immersed in the normal pressure and temperature water after the comminution by gas stream broken wall treatment, with ultrasonic Treatment, through rotating speed is 8000～10000 refrigerated centrifuger centrifugal treating of changeing, get supernatant, again with supernatant under-5～5 ℃ ambient temperature, cross the following molecular sieve of 4800D, isolate the bee pollen hydrotrope of molecular weight less than 4800D;
2) with molecular weight less than the bee pollen hydrotrope of 4800D after lyophilisation, obtain water content and be lower than 4% Herba leucadis ciliatae lyophilized powder;
3) with described Herba leucadis ciliatae lyophilized powder and water soluble starch mixing film-making.
2. according to the described method of claim 1, the frequency that it is characterized in that the classification motor of comminution by gas stream broken wall treatment in the described step 1) is 55～60Hz, and bleed pressure is 0.7～1.0MPa.
3. according to the described method of claim 1, it is characterized in that ultrasonic treatment time described in the described step 1) is 10～20 minutes.
4. according to the described method of claim 1, it is characterized in that described step 2) during lyophilisation, temperature of charge is-40 ℃～70 ℃ when sublimation drying and desorbing, vacuum condition is 3～7Pa.
5. according to the described method of claim 1, it is characterized in that the mass ratio when lyophilized powder and water soluble starch mix in the described step 3) is 1 ︰ 0.1～10.
6. according to the described method of claim 1, it is characterized in that in the described step 3), sneak into lecithin and microcrystalline Cellulose PH102 film-making.
7. according to the described method of claim 6, it is characterized in that the mass ratio when described lyophilized powder, lecithin, water soluble starch and microcrystalline Cellulose PH102 mix is 1 ︰, 0.1～10 ︰, 0.1～10 ︰ 0.1～10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106074388A CN102114049A (en) | 2010-12-28 | 2010-12-28 | Method for producing bee pollen tablets for treating premature ovarian failure of women |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106074388A CN102114049A (en) | 2010-12-28 | 2010-12-28 | Method for producing bee pollen tablets for treating premature ovarian failure of women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102114049A true CN102114049A (en) | 2011-07-06 |
Family
ID=44213049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010106074388A Pending CN102114049A (en) | 2010-12-28 | 2010-12-28 | Method for producing bee pollen tablets for treating premature ovarian failure of women |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102114049A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113662043A (en) * | 2021-08-12 | 2021-11-19 | 西北大学 | Functional bee pollen fermented goat yogurt and preparation method thereof |
-
2010
- 2010-12-28 CN CN2010106074388A patent/CN102114049A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113662043A (en) * | 2021-08-12 | 2021-11-19 | 西北大学 | Functional bee pollen fermented goat yogurt and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106421414B (en) | Preparation process of dendrobium officinale freeze-dried powder | |
| CN102302076B (en) | Synsepalum dulcificum natural taste-changing candies and preparation method thereof | |
| CN101214079A (en) | Barley seedling powder solid beverage and production technology thereof | |
| CN102630791A (en) | Preparation method of solid low-sugar ginger tea | |
| CN102114053B (en) | Method for producing pine pollen tablets for treating fatty liver | |
| CN105639659A (en) | Fiber food and production method thereof | |
| CN106473143A (en) | A kind of Herba Dendrobii lyophilized powder buccal tablet | |
| CN106072516A (en) | A kind of preparation method of Herba Dendrobii freeze-dried instant powder | |
| CN100496525C (en) | Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application | |
| CN105595143A (en) | Solid arecoline beverage and preparation method thereof | |
| CN105724642A (en) | Anti-oxidation anti-aging dark tea composition and preparation method | |
| CN101804056A (en) | Compound tablet of pioglitazone hydrochloride, glimepiride and preparation method thereof | |
| CN101658255B (en) | Bee pollen powder and preparation method thereof | |
| KR101423116B1 (en) | Method for producing ultrafine powder of adventitious root of wild grown ginseng using ultrafine grinder with cooling device and ultrafine powder of adventitious root of wild grown ginseng thereof | |
| CN102114049A (en) | Method for producing bee pollen tablets for treating premature ovarian failure of women | |
| CN102114058B (en) | Production method of bee pollen tablet for treating fatty liver | |
| CN106866691A (en) | A kind of method for extracting sesamin | |
| CN102114054A (en) | Production method of pine pollen tablets for treating premature ovarian failure of women | |
| CN105147899A (en) | Preparation for protecting stomach, protecting liver and dissipating effects of alcohol and application of preparation | |
| CN102114052A (en) | Production method of pine pollen soft capsule for treating fatty liver | |
| CN103211880A (en) | Phyllanthus emblica compound capsule and preparation method thereof | |
| CN102114057A (en) | Production method of pine pollen health tablets for treating sexual precocity of children | |
| CN104783177A (en) | Maca preparation | |
| CN102114048B (en) | Production method of bee pollen soft capsules for treating fatty liver | |
| CN104642699A (en) | Method for making qi and yang tonifying and health maintenance pressed candies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110706 |